Swiss All Share Index

Swiss All Share Index handeln
19.854,81 PKT +24,74 PKT +0,12 %
finanzen.net zero
Handle Aktien, ETFs, Derivate & Kryptos ohne Ordergebühren (zzgl. Spreads) beim ‘Kostensieger’ finanzen.net zero (Stiftung Warentest 12/2025)
Smartphone

ISIN CH0009111011


Analysen zu Swiss All Share Index-Werten

Datum Rating Analyst
18.10.12 BB Biotech halten Independent Research GmbH
18.10.12 Zurich Insurance neutral Credit Suisse Group
18.10.12 ABB (Asea Brown Boveri) buy Citigroup Corp.
18.10.12 UBS overweight Morgan Stanley
18.10.12 UBS equal-weight Morgan Stanley
18.10.12 Julius Bär equal-weight Morgan Stanley
18.10.12 Swiss Life buy Nomura
18.10.12 Givaudan sell Goldman Sachs Group Inc.
18.10.12 Nestlé buy Sarasin Research
18.10.12 Givaudan outperform Exane-BNP Paribas SA
18.10.12 UBS buy Deutsche Bank AG
18.10.12 UBS hold Deutsche Bank AG
18.10.12 Straumann hold Vontobel Research
18.10.12 Nestlé outperform Cheuvreux SA
18.10.12 Nestlé hold Vontobel Research
18.10.12 Zurich Insurance hold Société Générale Group S.A. (SG)
18.10.12 ABB (Asea Brown Boveri) buy Vontobel Research
18.10.12 Zurich Insurance outperform Keefe, Bruyette & Woods, Inc.
17.10.12 Givaudan overweight J.P. Morgan Cazenove
17.10.12 Zurich Insurance halten Independent Research GmbH
17.10.12 Novartis reduce Vontobel Research
17.10.12 Givaudan hold Vontobel Research
17.10.12 Novartis outperform Exane-BNP Paribas SA
17.10.12 Zurich Insurance neutral Sarasin Research
17.10.12 Zurich Insurance hold Vontobel Research
16.10.12 Nestlé neutral Credit Suisse Group
16.10.12 Novartis neutral Citigroup Corp.
16.10.12 Novartis underperform Banc of America Securities-Merrill Lynch
16.10.12 Nestlé buy Société Générale Group S.A. (SG)
16.10.12 ABB (Asea Brown Boveri) hold Société Générale Group S.A. (SG)
16.10.12 Kühne + Nagel International equal-weight Morgan Stanley
16.10.12 Kühne + Nagel International hold Deutsche Bank AG
16.10.12 Nestlé overweight Morgan Stanley
16.10.12 Kühne + Nagel International buy Nomura
16.10.12 Logitech outperform Exane-BNP Paribas SA
16.10.12 Clariant buy Vontobel Research
16.10.12 UBS neutral Macquarie Research
16.10.12 Novartis outperform Credit Suisse Group
15.10.12 UBS outperform Exane-BNP Paribas SA
15.10.12 Nestlé neutral HSBC